Ferring Pharmaceuticals to build biotechnology centre in Saint-Prex

Swiss biopharmaceutical company Ferring Pharmaceuticals announced plans to build a biotechnology centre at its headquarters in Saint-Prex, Switzerland, with an investment of more than CHF30m ($32.06m) over three years. The centre will develop biologic drugs and manufacture APIs for Rekovelle.

“The first lab of the biotech centre is expected to be operational in 2019.”pharmaceutical-technology.com

• 1 source
• pharmaceutical-technology.comFerring Pharmaceuticals Biotechnology Centre, Saint-Prex, SwitzerlandVasanthi VaraApr 5, 2018

Summarized from public sources; check the original articles before acting on it.